anti pd l1 (Proteintech)
Structured Review

Anti Pd L1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 655 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+pd+1/PD-L1%2FCD274+(C-terminal)+Antibody/pmc13620340-49-40-42
Average 96 stars, based on 655 article reviews
Images
1) Product Images from "SLAMF6 Enhances the Efficacy of Anti‐ PD ‐ L1 Immunotherapy in CRC Through the STAT1 / CXCL10 Signaling Axis"
Article Title: SLAMF6 Enhances the Efficacy of Anti‐ PD ‐ L1 Immunotherapy in CRC Through the STAT1 / CXCL10 Signaling Axis
Journal: Cancer Science
doi: 10.1111/cas.70530
Figure Legend Snippet: SLAMF6 enhances anti‐PD‐L1 immunotherapy in CRC via the STAT1/CXCL10 axis. SLAMF6 activates STAT1 to upregulate CXCL10, promoting CD8 + T‐cell recruitment into CRC tumor microenvironment. Together with anti‐PD‐L1, this enhances ICI efficacy.
Techniques Used:
Related Articles
Incubation:Article Title: Exogenous PD-L1 binds to PD-1 to alleviate and prevent autism-like behaviors in maternal immune activation-induced male offspring mice. Article Snippet: Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder caused by the interaction of multiple pathogenic factors.. Epidemiological studies and animal experiments indicate that maternal immune activation (MIA) is closely related to the development of ASD in offspring.. A large number of pro-inflammatory cytokines are transferred from the placenta to the fetal brain during MIA, which impedes fetal neurodevelopment and is accompanied by activation of immune cells and microglia. other:Article Title: A novel identified epithelial ligand-receptor-associated gene signature highlights POPDC3 as a potential therapy target for non-small cell lung cancer Article Snippet: The primary antibodies used were the following: Article Title: SARS-CoV-2 infection in brain tumors and the association with alterations in the tumor immune microenvironment. Article Snippet: The following antibodies were used in the current study: anti-SARS-CoV-2-NP (40143-MM05, 1:100; Sino Biological, Beijing, china); Article Title: A novel identified epithelial ligand-receptor-associated gene signature highlights POPDC3 as a potential therapy target for non-small cell lung cancer. Article Snippet: The primary antibodies used were the following: Article Title: Zuojin capsule improves T cell exhaustion and tumor immune microenvironment of hepatocellular carcinoma through the mTOR-eIF4E/p70S6K-CDK1 pathway Article Snippet: Membrane:Article Title: Exogenous PD-L1 binds to PD-1 to alleviate and prevent autism-like behaviors in maternal immune activation-induced male offspring mice. Article Snippet: Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder caused by the interaction of multiple pathogenic factors.. Epidemiological studies and animal experiments indicate that maternal immune activation (MIA) is closely related to the development of ASD in offspring.. A large number of pro-inflammatory cytokines are transferred from the placenta to the fetal brain during MIA, which impedes fetal neurodevelopment and is accompanied by activation of immune cells and microglia. Saline:Article Title: Exogenous PD-L1 binds to PD-1 to alleviate and prevent autism-like behaviors in maternal immune activation-induced male offspring mice. Article Snippet: Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder caused by the interaction of multiple pathogenic factors.. Epidemiological studies and animal experiments indicate that maternal immune activation (MIA) is closely related to the development of ASD in offspring.. A large number of pro-inflammatory cytokines are transferred from the placenta to the fetal brain during MIA, which impedes fetal neurodevelopment and is accompanied by activation of immune cells and microglia. Western Blot:Article Title: BMP9 Potentiates Immunotherapy in Triple-Negative Breast Cancer by Suppressing Tregs Infiltration via the PRKDC-CCL2 Axis. Article Snippet: Immunotherapy represents a pivotal strategy for triple-negative breast cancer (TNBC), yet its efficacy is constrained by the immunosuppressive tumor microenvironment (TME).. In this study, we demonstrate that bone morphogenetic protein-9 (BMP9) inhibits tumor growth and reprograms the immune TME in orthotopic TNBC models, primarily by attenuating regulatory T cells (Tregs) infiltration.. Tregs depletion abrogates si-BMP9mediated tumor promotion. Immunohistochemistry:Article Title: BMP9 Potentiates Immunotherapy in Triple-Negative Breast Cancer by Suppressing Tregs Infiltration via the PRKDC-CCL2 Axis. Article Snippet: Immunotherapy represents a pivotal strategy for triple-negative breast cancer (TNBC), yet its efficacy is constrained by the immunosuppressive tumor microenvironment (TME).. In this study, we demonstrate that bone morphogenetic protein-9 (BMP9) inhibits tumor growth and reprograms the immune TME in orthotopic TNBC models, primarily by attenuating regulatory T cells (Tregs) infiltration.. Tregs depletion abrogates si-BMP9mediated tumor promotion. |
